NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Jinhe Biotechnology CO. LTD (SHE: 002688)
002688 Technical Analysis
4
As on 27th Jan 2025 002688 STOCK Price closed @ 4.36 and we RECOMMEND Sell for LONG-TERM with Stoploss of 4.41 & Strong Sell for SHORT-TERM with Stoploss of 4.83 we also expect STOCK to react on Following IMPORTANT LEVELS. |
002688STOCK Price
Open | 4.30 | Change | Price | % |
High | 4.48 | 1 Day | 0.06 | 1.40 |
Low | 4.30 | 1 Week | 0.19 | 4.56 |
Close | 4.36 | 1 Month | -0.50 | -10.29 |
Volume | 12452834 | 1 Year | -0.51 | -10.47 |
52 Week High 5.18 | 52 Week Low 3.01 |
SHE China Most Active Stocks
002131 | 3.64 | -1.62% |
300059 | 22.94 | -4.77% |
000882 | 3.38 | -9.87% |
000564 | 2.59 | -5.47% |
000981 | 2.03 | -6.02% |
300170 | 19.59 | 0.15% |
002031 | 6.14 | -9.97% |
002122 | 3.97 | -7.46% |
000725 | 4.46 | -0.45% |
002354 | 6.10 | 4.45% |
SHE China Top Gainers Stocks
SHE China Top Losers Stocks
002688 Daily Charts |
002688 Intraday Charts |
Whats New @ Bazaartrend |
002688 Free Analysis |
|
002688 Important Levels Intraday
RESISTANCE | 4.71 |
RESISTANCE | 4.60 |
RESISTANCE | 4.53 |
RESISTANCE | 4.46 |
SUPPORT | 4.26 |
SUPPORT | 4.19 |
SUPPORT | 4.12 |
SUPPORT | 4.01 |
002688 Forecast February 2025
4th UP Forecast | 5.11 |
3rd UP Forecast | 4.87 |
2nd UP Forecast | 4.72 |
1st UP Forecast | 4.57 |
1st DOWN Forecast | 4.15 |
2nd DOWN Forecast | 4 |
3rd DOWN Forecast | 3.85 |
4th DOWN Forecast | 3.61 |
002688 Weekly Forecast
4th UP Forecast | 4.76 |
3rd UP Forecast | 4.63 |
2nd UP Forecast | 4.55 |
1st UP Forecast | 4.47 |
1st DOWN Forecast | 4.25 |
2nd DOWN Forecast | 4.17 |
3rd DOWN Forecast | 4.09 |
4th DOWN Forecast | 3.96 |
002688 Forecast2025
4th UP Forecast | 8.77 |
3rd UP Forecast | 7.36 |
2nd UP Forecast | 6.48 |
1st UP Forecast | 5.61 |
1st DOWN Forecast | 3.11 |
2nd DOWN Forecast | 2.24 |
3rd DOWN Forecast | 1.36 |
4th DOWN Forecast | -0.05 |
Jinhe Biotechnology CO. LTD ( SHE China Symbol : 002688 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
002688 Other Details
Segment | EQ | |
Market Capital | 4097215488.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
002688 Address
002688 Latest News
002688 Business Profile
Jinhe Biotechnology CO., LTD. produces and sells veterinary medicines in China. The company offers chlortetracycline feed grade, an antimicrobial drug for the inhibition and treatment of white dysentery, enteritis, pheumonia, typhoid, paratyphoid, cholera, etc. in poultry and livestock; and chlortetracycline hydrochloride for the inhibition and treatment of pullorum disease, typhoid, and swine enteritis, as well as bacterial diseases, including paratyphoid and cholera. It also exports its products to the United States, South-east Asia, Latin America, Europe, etc. The company is based in Dalian, China. Address: 1-7-2 Building 27, Dalian, China, 116023
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service